| [1] |
Manns MP, Buti M, Gane E, et al. Hepatitis C virus infection. Nat Rev Dis Primers, 2017, 3:17006.
|
| [2] |
Bal A, Petrova A. Single clinical practice's report of testing initiation, antibody clearance, and transmission of hepatitis C virus (HCV) in infants of chronically HCV-infected mothers. Open Forum Infect Dis, 2016, 3:ofw021.
|
| [3] |
Salemi JL, Spooner KK, Mejia de Grubb MC, et al. National trends of hepatitis B and C during pregnancy across sociodemographic, behavioral, and clinical factors, United States, 1998-2011. J Med Virol, 2016, 89: 1025-1032.
|
| [4] |
Koneru A, Nelson N, Hariri S, et al. Increased hepatitis C virus (HCV) detection in women of childbearing age and potential risk for vertical transmission-United States and Kentucky, 2011-2014. MMWR Morb Mortal Wkly Rep, 2016, 65: 705-710.
|
| [5] |
Ahmad I. Prevalence of hepatitis B and C viral infection among pregnant women in peshawar, Pakistan. Hepat Mon, 2016, 16: e36383.
|
| [6] |
Khamis HH, Farghaly AG, Shatat HZ, et al. Prevalence of hepatitis C virus infection among pregnant women in a rural district in Egypt. Trop Doct, 2016, 46: 21-27.
|
| [7] |
Elrazek AE, Amer M, Hawary B, et al. Prediction of HCV vertical transmission: What are factors should be optimized using data mining computational analysis. Liver Int, 2017, 37: 529-533.
|
| [8] |
Garcia-Tejedor A, Maiques-Montesinos V, Diago-Almela VJ, et al. Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers. Eur J Obstet Gynecol Reprod Biol, 2015, 194:173-177.
|
| [9] |
Hurtado CW, Golden-Mason L, Brocato M, et al. Innate immune function in placenta and cord blood of hepatitis C-seropositive mother-infant dyads. PLoS One, 2010, 5: e12232.
|
| [10] |
Nie QH, Gao LH, Cheng YQ, et al. Hepatitis C virus infection of human cytotrophoblasts cultured in vitro. J Med Virol, 2012, 84: 1586-1592.
|
| [11] |
Babik JM, Cohan D, Monto A, et al. The human fetal immune response to hepatitis C virus exposure in utero. J Infect Dis, 2011, 203: 196-206.
|
| [12] |
Ma M, Zhu Y, Wang D, et al. Research on the vertical transmission of hepatitis C gene from father-to-child via human sperm. Clin Lab, 2016, 62: 1-6.
|
| [13] |
Paternoster DM, Santarossa C, Grella P, et al. Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol, 2001, 96: 2751-2754.
|
| [14] |
Yeung LT, To T, King SM, et al. Spontaneous clearance of childhood hepatitis C virus infection. J Viral Hepat, 2007, 14: 797-805.
|
| [15] |
卢广娟. 妊娠时丙型肝炎病毒感染的临床研究进展. 肝脏, 2014, 19: 549-551.
|
| [16] |
El-Guindi MA. Hepatitis C viral infection in children: Updated review. Pediatr Gastroenterol Hepatol Nutr, 2016, 19: 83-95.
|
| [17] |
Guido M, Bortolotti F. Viral hepatitis: Treating hepatitis C in children: an open horizon. Nat Rev Gastroenterol Hepatol, 2011, 8: 247-248.
|
| [18] |
Kuncio DE, Newbern EC, Johnson CC, et al. Failure to test and identify perinatally infected children born to hepatitis C virus-infected women. Clin Infect Dis, 2016, 62: 980-985.
|
| [19] |
Selvapatt N, Ward T, Bailey H, et al. Is antenatal screening for hepatitis C virus cost-effective? A decade's experience at a London centre. J Hepatol, 2015, 63: 797-804.
|
| [20] |
Ghazaryan L, Smith L, Parker M, et al. Hepatitis C seroprevalence among HIV-infected childbearing women in new york state in 2006. Matern Child Health J, 2016, 20: 550-555.
|
| [21] |
Benova L, Mohamoud YA, Calvert C, et al. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis, 2014, 59: 765-773.
|
| [22] |
Hayashida A, Inaba N, Oshima K, et al. Re-evaluation of the true rate of hepatitis C virus mother-to-child transmission and its novel risk factors based on our two prospective studies. J Obstet Gynaecol Res, 2007, 33: 417-422.
|
| [23] |
Wijarnpreecha K, Thongprayoon C, Sanguankeo A, et al. Hepatitis C infection and intrahepatic cholestasis of pregnancy: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol, 2017, 41: 39-45.
|
| [24] |
Dunkelberg JC, Berkley EM, Thiel KW, et al. Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol, 2014, 34: 882-891.
|
| [25] |
Huang QT, Hang LL, Zhong M, et al. Maternal HCV infection is associated with intrauterine fetal growth disturbance: A meta-analysis of observational studies. Medicine (Baltimore), 2016, 95: e4777.
|
| [26] |
Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med, 2016, 374: 2324-2334.
|
| [27] |
Yazdani Brojeni P, Matok I, Garcia Bournissen F, et al. A systematic review of the fetal safety of interferon alpha. Reprod Toxicol, 2012, 33: 265-268.
|
| [28] |
Roberts SS, Miller RK, Jones JK, et al. The ribavirin pregnancy registry: Findings after 5 years of enrollment, 2003-2009. Birth Defects Res A Clin Mol Teratol, 2010, 88: 551-559.
|
| [29] |
中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2015更新版). 肝脏, 2015, 20: 933-949,1006.
|
| [30] |
KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol, 2016, 22: 76-139.
|
| [31] |
Cuenca-Lopez F, Rivero A, Rivero-Juarez A. Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis C. Expert Opin Drug Metab Toxicol, 2017, 13: 105-112.
|
| [32] |
Spera AM, Eldin TK, Tosone G, et al. Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women? World J Hepatol, 2016, 8: 557-565.
|
| [33] |
EASL Recommendations on Treatment of Hepatitis C 2015. J Hepatol, 2015, 63 :199-236.
|
